On 16 December 2025, the European Commission proposed a package of measures to improve the health of EU citizens, while ensuring the long-term resilience and competitiveness of the EU health sector.

Xtalks is pleased to announce its role as an official Media Partner for the Toronto Life Sciences and Biotech Summit, taking ...

In this article, we will be taking a look at the 10 Best Biotech Stocks Under $10 to Buy. According to Eli Casdin, CEO of ...

GenScript Biotech Corporation today announced its 2025 Environmental, Social, and Governance (ESG) Report, positioning the ...

If Biotech manages to break out to new highs at some point this year, it would clear a significant resistance hurdle and open ...

It was as recently as February that biotech CEOs were talking enthusiastically to Fierce about a positive “shift in the ...

The latest trial milestone sends this ASX biotech stock higher today. The post This ASX biotech stock just jumped again as ...

Immutep shares rocket after a fresh FDA win The post Why this ASX biotech stock just rocketed 89% today appeared first on The ...

Climb Bio, Inc. stays a Buy on budoprutug pMN data; Phase 2 PrisMN readout 2H 2026 + SLE/ITP upside and 2028 cash runway.

The multipronged organization has a lab space on the working waterfront and an academy, the Gloucester Biotechnology Academy, ...

New Jersey's Johnson & Johnson grew from one ambitious pharmacist to a $94 billion pharmaceutical and medical device giant.

Streamlining clinical trials, harmonising regulations and improving access to capital should be driving biotech efforts, ...